When APC is mutated, which occurs in up to 80% of colorectal cancer, β-catenin accumulates and translocates to the nucleus, where it binds the transcription factors of the TCF/LEF gene family and activates the expression of target genes (Korinek et al, 1997). This evidence concerns the gene APC and colorectal cancer.